Remedium Lifecare Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹111.06 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.04 per cent from ₹113.37 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Operating Profit
Operating Profit stands at ₹7.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 294.12 per cent from ₹1.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
PBDT
PBDT stands at ₹10.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.66 per cent from ₹5.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹10.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.66 per cent from ₹5.71 crore. This corresponds to a year-on-year *(YoY) decline of 0.00 per cent.
Net Profit
Net Profit stands at ₹8.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 85.38 per cent from ₹4.65 crore. This represents a 0.00 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Remedium Lifecare Ltd Earnings
- YOY
- QOQ
Remedium Lifecare Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Remedium Lifecare Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Remedium Lifecare Ltd Financial Reports
Remedium Lifecare Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Remedium Life | -3.70% | -7.14% | -18.75% | -3.70% | -42.22% | -82.89% |
| Bacil Pharma | 4.31% | 20.67% | 40.33% | -50.70% | -58.97% | -41.71% |
| Deep Health AI | -1.09% | -2.67% | -8.08% | -19.47% | -37.46% | -57.87% |
| Medico Intercon. | 2.00% | 2.78% | -8.96% | -0.04% | -21.56% | -31.29% |
| Venmax Drugs | 3.47% | -0.64% | -11.43% | -28.14% | -38.88% | -40.50% |
| Ishita Drugs | -0.34% | -0.34% | 3.57% | 0.07% | -11.75% | -3.67% |
| Pentokey Organy | -6.34% | 0.03% | 3.00% | -12.82% | -7.81% | -24.48% |
Company Info
Company Information
Whole-time Director : Adarsh Deepak Munjal
Independent Non Exe. Director : Dipesh Vaidya
Independent Non Exe. Director : Shamim Adil Michal
Independent Non Exe. Director : Bikram Kumar Mund
Independent Non Exe. Director : VIJAY PAL SINGH GULYA
Company Sec. & Compli. Officer : Kapil Goplani